419 related articles for article (PubMed ID: 11511026)
21. Mometasone furoate dry-powder inhaler for the control of persistent asthma.
D'Urzo A
Expert Opin Pharmacother; 2007 Nov; 8(16):2871-84. PubMed ID: 17956206
[TBL] [Abstract][Full Text] [Related]
22. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
[TBL] [Abstract][Full Text] [Related]
23. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[TBL] [Abstract][Full Text] [Related]
24. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
Fish JE; Karpel JP; Craig TJ; Bensch GW; Noonan M; Webb DR; Silverman B; Schenkel EJ; Rooklin AR; Ramsdell JW; Nathan R; Leflein JG; Grossman J; Graft DF; Gower RG; Garay SM; Frigas E; Degraff AC; Bronsky EA; Bernstein DI; Berger W; Shneyer L; Nolop KB; Harrison JE
J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706
[TBL] [Abstract][Full Text] [Related]
25. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
Harnest U; Price D; Howes T; Sussman G
J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
[TBL] [Abstract][Full Text] [Related]
26. Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma.
Zeidler M; Corren J; Tashkin DP
Curr Med Res Opin; 2010 Jun; 26(6):1295-305. PubMed ID: 20370376
[TBL] [Abstract][Full Text] [Related]
27. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients.
Drouin M; Yang WH; Bertrand B; Van Cauwenberge P; Clement P; Dalby K; Darnell R; Ernst TM; Hébert J; Karlsson G; Luciuk G; Mazza J; Roovers M; Ruoppi P; Seppey M; Stern M; Suonpää J; Sussman G; Tan KY; Tse K; Widjaja P; Jensen P; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1996 Aug; 77(2):153-60. PubMed ID: 8760782
[TBL] [Abstract][Full Text] [Related]
28. Mometasone furoate versus beclomethasone dipropionate: effectiveness in patients with mild asthma.
Friedman HS; Urdaneta E; McLaughlin JM; Navaratnam P
Am J Manag Care; 2010 Jul; 16(7):e151-6. PubMed ID: 20645660
[TBL] [Abstract][Full Text] [Related]
29. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
[TBL] [Abstract][Full Text] [Related]
30. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study.
Price D; Robertson A; Bullen K; Rand C; Horne R; Staudinger H
BMC Pulm Med; 2010 Jan; 10():1. PubMed ID: 20051135
[TBL] [Abstract][Full Text] [Related]
31. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.
Crim C; Pierre LN; Daley-Yates PT
Clin Ther; 2001 Sep; 23(9):1339-54. PubMed ID: 11589253
[TBL] [Abstract][Full Text] [Related]
32. Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis.
Kosoglou T; Cutler DL; Staudinger H; Herron JM
Chest; 2010 Jan; 137(1):115-21. PubMed ID: 19749003
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.
Bousquet J; D'Urzo A; Hebert J; Barraza CH; Boulet LP; Suárez-Chacón R; Harnest U; Lundbäck B; Martinez Morales G; Nieminen MM; Nolop KB; Visser S; Lutsky BN
Eur Respir J; 2000 Nov; 16(5):808-16. PubMed ID: 11153576
[TBL] [Abstract][Full Text] [Related]
34. Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma: a randomized, double-blind, placebo-controlled pilot study.
Krouse JH; Krouse HJ; Janisse JJ
Clin Drug Investig; 2009; 29(1):51-8. PubMed ID: 19067474
[TBL] [Abstract][Full Text] [Related]
35. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
Kosoglou T; Hubbell J; Xuan F; Cutler DL; Meehan AG; Kantesaria B; Wittmer BA
Int J Chron Obstruct Pulmon Dis; 2013; 8():107-16. PubMed ID: 23525511
[TBL] [Abstract][Full Text] [Related]
37. Once-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: an active- and placebo-controlled study.
Hebert JR; Nolop K; Lutsky BN
Allergy; 1996 Aug; 51(8):569-76. PubMed ID: 8874661
[TBL] [Abstract][Full Text] [Related]
38. Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma.
Schmier J; Leidy NK; Gower R
J Asthma; 2003 Jun; 40(4):383-93. PubMed ID: 12870834
[TBL] [Abstract][Full Text] [Related]
39. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
Bernstein DI; Berkowitz RB; Chervinsky P; Dvorin DJ; Finn AF; Gross GN; Karetzky M; Kemp JP; Laforce C; Lumry W; Mendelson LM; Nelson H; Pearlman D; Rachelefsky G; Ratner P; Repsher L; Segal AT; Selner JC; Settipane GA; Wanderer A; Cuss FM; Nolop KB; Harrison JE
Respir Med; 1999 Sep; 93(9):603-12. PubMed ID: 10542973
[TBL] [Abstract][Full Text] [Related]
40. Fluticasone furoate/vilanterol: a review of its use in patients with asthma.
Syed YY
Drugs; 2015 Mar; 75(4):407-18. PubMed ID: 25648266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
